Home Zombies

zombies

How the SEC views conflicts in GP-led restructurings

The SEC’s Igor Rozenblit explained last week at a PEI event in New York why some end-of-life situations can create conflicts of interest, particularly regarding fees and expenses.

The good, the bad and the old: finding value in challenging deals

Reporter Adam Le here, filling in while Marine's on the West Coast. Two stories I reported on this week stood out in my mind as they both involved older funds and how – and whether – to find value in them.

Zombie funds represent $393bn in funds raised

The majority of zombie funds focus on North America, with buyout as the main strategy, according to PEI's Research and Analytics division.

The view from Chicago

Talking to market participants in Chicago this week, three clear themes emerged: buyers are becoming sellers, restructurings are here to stay and return expectation are way down.

Secondaries Roundtable: NAV is just a number

Navigating full pricing, the rise of restructurings and the use of seller financing in today’s booming secondaries market were among the topics debated recently in New York at a PEI roundtable.

Why HarbourVest won the Doughty deal

Long-standing relationships and LP-friendly terms were key elements in HarbourVest’s €215m stapled transaction with Doughty Hanson.

Inside ICG’s secondaries ambitions

The ICG-NewGlobe development highlights continuing shifts in the secondaries market.

Evoco quadruples headcount since January

The Swiss direct secondaries firm is led by partners Felix Ackermann (pictured) and Michel Galeazzi.

Tullett Prebon: GP support to drive auction success

GPs taking the lead on liquidity events will draw more investors to private equity and drive secondaries pricing up, according to Neil Campbell, head of Tullett Prebon Alternative Investments.

Wisconsin sells 3i stake to Strategic Partners

3i Eurofund III raised €2.3bn in 1999 and invested into European mid-market companies, including Swiss transportation and service provider SR Technics.